Therapeutic Drug Monitoring Market Size, Share Report, Analysis, Trends, Growth 2030

Creator: Zion Market Research
License: https://www.zionmarketresearch.com/privacy-policy

Therapeutic Drug Monitoring Market by Product Split (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors , Clinical Chemistry Analyzers), By Technology Split (Immunoassays., Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassays, Other Immunoassays, Chromatography-MS, LC-MS, GC-MS), By Class of drug Split (Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs), By End User Split (Hospital Laboratories, Commercial & Private Laboratories, Other End Users) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2021 - 2028

Category: Healthcare Report Format : PDF Pages: 188 Report Code: ZMR-3497 Published Date: May-2022 Status : Published

Global Therapeutic Drug Monitoring market was worth $1,692.9 billion in 2021 and is expected to reach $2854.83 billion by 2028, growing at a CAGR of 9.10%.

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Therapeutic Drug Monitoring Market, (2022 - 2028) (USD Billion )
- 2.2 Global Therapeutic Drug Monitoring Market : snapshot
Chapter 3. Global Therapeutic Drug Monitoring Market - Industry Analysis
- 3.1 Therapeutic Drug Monitoring Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increasing preference for precision medicine of the market growth
- 3.3 Market Restraints
  - 3.3.1. Operational barriers faced in conducting TDM tests of the market growth
- 3.4 Market Opportunities
  - 3.4.1. Increasing adoption in the treatment of autoimmune diseases of the market growth
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Product Split
  - 3.7.2 Market attractiveness analysis By Technology Split
  - 3.7.3 Market attractiveness analysis By Class of drug Split
  - 3.7.4 Market attractiveness analysis By End user Split
Chapter 4. Global Therapeutic Drug Monitoring Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Therapeutic Drug Monitoring Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Therapeutic Drug Monitoring Market - Product Split Analysis
- 5.1 Global Therapeutic Drug Monitoring Market overview: By Product Split
  - 5.1.1 Global Therapeutic Drug Monitoring Market share, By Product Split, 2021 and 2028
- 5.2 Consumables
  - 5.2.1 Global Therapeutic Drug Monitoring Market by Consumables, 2022 - 2028 (USD Billion )
- 5.3 Equipment
  - 5.3.1 Global Therapeutic Drug Monitoring Market by Equipment, 2022 - 2028 (USD Billion )
- 5.4 Immunoassay Analyzers
  - 5.4.1 Global Therapeutic Drug Monitoring Market by Immunoassay Analyzers, 2022 - 2028 (USD Billion )
- 5.5 Chromatography & MS Detectors
  - 5.5.1 Global Therapeutic Drug Monitoring Market by Chromatography & MS Detectors, 2022 - 2028 (USD Billion )
- 5.6 Clinical Chemistry Analyzers
  - 5.6.1 Global Therapeutic Drug Monitoring Market by Clinical Chemistry Analyzers, 2022 - 2028 (USD Billion )
Chapter 6. Global Therapeutic Drug Monitoring Market - Technology Split Analysis
- 6.1 Global Therapeutic Drug Monitoring Market overview: By Technology Split
  - 6.1.1 Global Therapeutic Drug Monitoring Market share, By Technology Split, 2021 and 2028
- 6.2 Immunoassays.
  - 6.2.1 Global Therapeutic Drug Monitoring Market by Immunoassays., 2022 - 2028 (USD Billion )
- 6.3 Chemiluminescence Immunoassays
  - 6.3.1 Global Therapeutic Drug Monitoring Market by Chemiluminescence Immunoassays, 2022 - 2028 (USD Billion )
- 6.4 Colorimetric Immunoassays
  - 6.4.1 Global Therapeutic Drug Monitoring Market by Colorimetric Immunoassays, 2022 - 2028 (USD Billion )
- 6.5 Fluorescence Immunoassays
  - 6.5.1 Global Therapeutic Drug Monitoring Market by Fluorescence Immunoassays, 2022 - 2028 (USD Billion )
- 6.6 Radioimmunoassays
  - 6.6.1 Global Therapeutic Drug Monitoring Market by Radioimmunoassays, 2022 - 2028 (USD Billion )
- 6.7 Other Immunoassays
  - 6.7.1 Global Therapeutic Drug Monitoring Market by Other Immunoassays, 2022 - 2028 (USD Billion )
- 6.8 Chromatography-MS
  - 6.8.1 Global Therapeutic Drug Monitoring Market by Chromatography-MS, 2022 - 2028 (USD Billion )
- 6.9 LC-MS
  - 6.9.1 Global Therapeutic Drug Monitoring Market by LC-MS, 2022 - 2028 (USD Billion )
- 6.10 GC-MS
  - 6.10.1 Global Therapeutic Drug Monitoring Market by GC-MS, 2022 - 2028 (USD Billion )
Chapter 7. Global Therapeutic Drug Monitoring Market - Class of drug Split Analysis
- 7.1 Global Therapeutic Drug Monitoring Market overview: By Class of drug Split
  - 7.1.1 Global Therapeutic Drug Monitoring Market share, By Class of drug Split, 2021 and 2028
- 7.2 Antiepileptic Drugs
  - 7.2.1 Global Therapeutic Drug Monitoring Market by Antiepileptic Drugs, 2022 - 2028 (USD Billion )
- 7.3 Antibiotic Drugs
  - 7.3.1 Global Therapeutic Drug Monitoring Market by Antibiotic Drugs, 2022 - 2028 (USD Billion )
- 7.4 Immunosuppressant Drugs
  - 7.4.1 Global Therapeutic Drug Monitoring Market by Immunosuppressant Drugs, 2022 - 2028 (USD Billion )
- 7.5 Antiarrhythmic Drugs
  - 7.5.1 Global Therapeutic Drug Monitoring Market by Antiarrhythmic Drugs, 2022 - 2028 (USD Billion )
- 7.6 Bronchodilator Drugs
  - 7.6.1 Global Therapeutic Drug Monitoring Market by Bronchodilator Drugs, 2022 - 2028 (USD Billion )
- 7.7 Psychoactive Drugs
  - 7.7.1 Global Therapeutic Drug Monitoring Market by Psychoactive Drugs, 2022 - 2028 (USD Billion )
- 7.8 Other Drugs
  - 7.8.1 Global Therapeutic Drug Monitoring Market by Other Drugs, 2022 - 2028 (USD Billion )
Chapter 8. Global Therapeutic Drug Monitoring Market - End user Split Analysis
- 8.1 Global Therapeutic Drug Monitoring Market overview: By End user Split
  - 8.1.1 Global Therapeutic Drug Monitoring Market share, By End user Split, 2021 and 2028
- 8.2 Hospital Laboratories
  - 8.2.1 Global Therapeutic Drug Monitoring Market by Hospital Laboratories, 2022 - 2028 (USD Billion )
- 8.3 Commercial & Private Laboratories
  - 8.3.1 Global Therapeutic Drug Monitoring Market by Commercial & Private Laboratories, 2022 - 2028 (USD Billion )
- 8.4 Other End Users
  - 8.4.1 Global Therapeutic Drug Monitoring Market by Other End Users, 2022 - 2028 (USD Billion )
Chapter 9. Therapeutic Drug Monitoring Market - Regional Analysis
- 9.1 Global Therapeutic Drug Monitoring Market Regional Overview
- 9.2 Global Therapeutic Drug Monitoring Market Share, by Region, 2021 & 2028 (USD Billion )
- 9.3. North America
  - 9.3.1 North America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
    - 9.3.1.1 North America Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
- 9.4 North America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
  - 9.4.1 North America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
- 9.5 North America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
  - 9.5.1 North America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
- 9.6 North America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
  - 9.6.1 North America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
- 9.7 North America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
  - 9.7.1 North America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
- 9.4. Europe
  - 9.4.2 Europe Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
    - 9.4.2.1 Europe Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
- 9.4 Europe Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
  - 9.4.1 Europe Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
- 9.5 Europe Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
  - 9.5.1 Europe Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
- 9.6 Europe Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
  - 9.6.1 Europe Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
- 9.7 Europe Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
  - 9.7.1 Europe Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
- 9.5. Asia Pacific
  - 9.5.3 Asia Pacific Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
    - 9.5.3.1 Asia Pacific Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
- 9.4 Asia Pacific Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
  - 9.4.1 Asia Pacific Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
- 9.5 Asia Pacific Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
  - 9.5.1 Asia Pacific Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
- 9.6 Asia Pacific Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
  - 9.6.1 Asia Pacific Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
- 9.7 Asia Pacific Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
  - 9.7.1 Asia Pacific Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
- 9.6. Latin America
  - 9.6.4 Latin America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
    - 9.6.4.1 Latin America Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
- 9.4 Latin America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
  - 9.4.1 Latin America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
- 9.5 Latin America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
  - 9.5.1 Latin America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
- 9.6 Latin America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
  - 9.6.1 Latin America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
- 9.7 Latin America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
  - 9.7.1 Latin America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
- 9.7. The Middle-East and Africa
  - 9.7.5 The Middle-East and Africa Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
    - 9.7.5.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
- 9.4 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
  - 9.4.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
- 9.5 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
  - 9.5.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
- 9.6 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
  - 9.6.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
- 9.7 The Middle-East and Africa Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
  - 9.7.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
Chapter 10. Company Profiles
- 10.1 Abbott (US)
  - 10.1.1 Overview
  - 10.1.2 Financials
  - 10.1.3 Product Portfolio
  - 10.1.4 Business Strategy
  - 10.1.5 Recent Developments
- 10.2 Thermo Fisher Scientific (US)
  - 10.2.1 Overview
  - 10.2.2 Financials
  - 10.2.3 Product Portfolio
  - 10.2.4 Business Strategy
  - 10.2.5 Recent Developments
- 10.3 F. Hoffmann-La Roche Ltd. (Switzerland)
  - 10.3.1 Overview
  - 10.3.2 Financials
  - 10.3.3 Product Portfolio
  - 10.3.4 Business Strategy
  - 10.3.5 Recent Developments
- 10.4 Siemens Healthineers AG (Germany)
  - 10.4.1 Overview
  - 10.4.2 Financials
  - 10.4.3 Product Portfolio
  - 10.4.4 Business Strategy
  - 10.4.5 Recent Developments
- 10.5 Danaher Corporation (US)
  - 10.5.1 Overview
  - 10.5.2 Financials
  - 10.5.3 Product Portfolio
  - 10.5.4 Business Strategy
  - 10.5.5 Recent Developments
- 10.6 Bio-Rad Laboratories (US)
  - 10.6.1 Overview
  - 10.6.2 Financials
  - 10.6.3 Product Portfolio
  - 10.6.4 Business Strategy
  - 10.6.5 Recent Developments
- 10.7 bioMérieux SA (France)
  - 10.7.1 Overview
  - 10.7.2 Financials
  - 10.7.3 Product Portfolio
  - 10.7.4 Business Strategy
  - 10.7.5 Recent Developments
- 10.8 Theradiag SA (France)
  - 10.8.1 Overview
  - 10.8.2 Financials
  - 10.8.3 Product Portfolio
  - 10.8.4 Business Strategy
  - 10.8.5 Recent Developments
- 10.9 Grifols S.A. (Spain)
  - 10.9.1 Overview
  - 10.9.2 Financials
  - 10.9.3 Product Portfolio
  - 10.9.4 Business Strategy
  - 10.9.5 Recent Developments
- 10.10 Exagen Inc. (US)
  - 10.10.1 Overview
  - 10.10.2 Financials
  - 10.10.3 Product Portfolio
  - 10.10.4 Business Strategy
  - 10.10.5 Recent Developments
- 10.11 R-Biopharm AG (Germany)
  - 10.11.1 Overview
  - 10.11.2 Financials
  - 10.11.3 Product Portfolio
  - 10.11.4 Business Strategy
  - 10.11.5 Recent Developments
- 10.12 ApDia Group (Belgium)
  - 10.12.1 Overview
  - 10.12.2 Financials
  - 10.12.3 Product Portfolio
  - 10.12.4 Business Strategy
  - 10.12.5 Recent Developments
- 10.13 UTAK (US)
  - 10.13.1 Overview
  - 10.13.2 Financials
  - 10.13.3 Product Portfolio
  - 10.13.4 Business Strategy
  - 10.13.5 Recent Developments
- 10.14 Randox Laboratories Ltd. (Ireland)
  - 10.14.1 Overview
  - 10.14.2 Financials
  - 10.14.3 Product Portfolio
  - 10.14.4 Business Strategy
  - 10.14.5 Recent Developments
- 10.15 ARK Diagnostics
  - 10.15.1 Overview
  - 10.15.2 Financials
  - 10.15.3 Product Portfolio
  - 10.15.4 Business Strategy
  - 10.15.5 Recent Developments
- 10.16 Inc. (US). BioTeZ Berlin-Buch GmbH (Germany)
  - 10.16.1 Overview
  - 10.16.2 Financials
  - 10.16.3 Product Portfolio
  - 10.16.4 Business Strategy
  - 10.16.5 Recent Developments
- 10.17 Eagle Biosciences Inc. (US)
  - 10.17.1 Overview
  - 10.17.2 Financials
  - 10.17.3 Product Portfolio
  - 10.17.4 Business Strategy
  - 10.17.5 Recent Developments
- 10.18 Jasem Laboratory Systems and Solutions (Turkey)
  - 10.18.1 Overview
  - 10.18.2 Financials
  - 10.18.3 Product Portfolio
  - 10.18.4 Business Strategy
  - 10.18.5 Recent Developments
- 10.19 Aalto Scientific Ltd. (US)
  - 10.19.1 Overview
  - 10.19.2 Financials
  - 10.19.3 Product Portfolio
  - 10.19.4 Business Strategy
  - 10.19.5 Recent Developments
- 10.20 Immundiagnostik AG (Germany)
  - 10.20.1 Overview
  - 10.20.2 Financials
  - 10.20.3 Product Portfolio
  - 10.20.4 Business Strategy
  - 10.20.5 Recent Developments
- 10.21 Sekisui Medical Co. Ltd. (Japan)
  - 10.21.1 Overview
  - 10.21.2 Financials
  - 10.21.3 Product Portfolio
  - 10.21.4 Business Strategy
  - 10.21.5 Recent Developments
- 10.22 DiaSystem Scandinavia AB (Sweden)
  - 10.22.1 Overview
  - 10.22.2 Financials
  - 10.22.3 Product Portfolio
  - 10.22.4 Business Strategy
  - 10.22.5 Recent Developments
- 10.23 Cambridge Life Sciences Limited (UK)
  - 10.23.1 Overview
  - 10.23.2 Financials
  - 10.23.3 Product Portfolio
  - 10.23.4 Business Strategy
  - 10.23.5 Recent Developments
- 10.24 Chromsystems Instruments & Chemicals GmbH (Germany)
  - 10.24.1 Overview
  - 10.24.2 Financials
  - 10.24.3 Product Portfolio
  - 10.24.4 Business Strategy
  - 10.24.5 Recent Developments
- 10.25 BÜHLMANN Laboratories (Switzerland).
  - 10.25.1 Overview
  - 10.25.2 Financials
  - 10.25.3 Product Portfolio
  - 10.25.4 Business Strategy
  - 10.25.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
4. Porter’s Five Forces Analysis
5. Global Therapeutic Drug Monitoring Market attractiveness, By Product Split
6. Global Therapeutic Drug Monitoring Market attractiveness, By Technology Split
7. Global Therapeutic Drug Monitoring Market attractiveness, By Class of drug Split
8. Global Therapeutic Drug Monitoring Market attractiveness, By End user Split
9. Global Therapeutic Drug Monitoring Market share by Product Split, 2022 and 2028 (USD Billion )
10. Global Therapeutic Drug Monitoring Market by Consumables, 2022 - 2028 (USD Billion )
11. Global Therapeutic Drug Monitoring Market by Equipment, 2022 - 2028 (USD Billion )
12. Global Therapeutic Drug Monitoring Market by Immunoassay Analyzers, 2022 - 2028 (USD Billion )
13. Global Therapeutic Drug Monitoring Market by Chromatography & MS Detectors, 2022 - 2028 (USD Billion )
14. Global Therapeutic Drug Monitoring Market by Clinical Chemistry Analyzers, 2022 - 2028 (USD Billion )
15. Global Therapeutic Drug Monitoring Market share by Technology Split, 2022 and 2028 (USD Billion )
16. Global Therapeutic Drug Monitoring Market by Immunoassays., 2022 - 2028 (USD Billion )
17. Global Therapeutic Drug Monitoring Market by Chemiluminescence Immunoassays, 2022 - 2028 (USD Billion )
18. Global Therapeutic Drug Monitoring Market by Colorimetric Immunoassays, 2022 - 2028 (USD Billion )
19. Global Therapeutic Drug Monitoring Market by Fluorescence Immunoassays, 2022 - 2028 (USD Billion )
20. Global Therapeutic Drug Monitoring Market by Radioimmunoassays, 2022 - 2028 (USD Billion )
21. Global Therapeutic Drug Monitoring Market by Other Immunoassays, 2022 - 2028 (USD Billion )
22. Global Therapeutic Drug Monitoring Market by Chromatography-MS, 2022 - 2028 (USD Billion )
23. Global Therapeutic Drug Monitoring Market by LC-MS, 2022 - 2028 (USD Billion )
24. Global Therapeutic Drug Monitoring Market by GC-MS, 2022 - 2028 (USD Billion )
25. Global Therapeutic Drug Monitoring Market share by Class of drug Split, 2022 and 2028 (USD Billion )
26. Global Therapeutic Drug Monitoring Market by Antiepileptic Drugs, 2022 - 2028 (USD Billion )
27. Global Therapeutic Drug Monitoring Market by Antibiotic Drugs, 2022 - 2028 (USD Billion )
28. Global Therapeutic Drug Monitoring Market by Immunosuppressant Drugs, 2022 - 2028 (USD Billion )
29. Global Therapeutic Drug Monitoring Market by Antiarrhythmic Drugs, 2022 - 2028 (USD Billion )
30. Global Therapeutic Drug Monitoring Market by Bronchodilator Drugs, 2022 - 2028 (USD Billion )
31. Global Therapeutic Drug Monitoring Market by Psychoactive Drugs, 2022 - 2028 (USD Billion )
32. Global Therapeutic Drug Monitoring Market by Other Drugs, 2022 - 2028 (USD Billion )
33. Global Therapeutic Drug Monitoring Market share by End user Split, 2022 and 2028 (USD Billion )
34. Global Therapeutic Drug Monitoring Market by Hospital Laboratories, 2022 - 2028 (USD Billion )
35. Global Therapeutic Drug Monitoring Market by Commercial & Private Laboratories, 2022 - 2028 (USD Billion )
36. Global Therapeutic Drug Monitoring Market by Other End Users, 2022 - 2028 (USD Billion )
37. Global Therapeutic Drug Monitoring Market share, by Region, 2022 and 2028
38. North America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
39. Europe Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
40. Asia Pacific Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
41. Latin America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
42. The Middle-East and Africa Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )

Table Of Tables

1. Global Therapeutic Drug Monitoring Market: Snapshot
2. Drivers of the Therapeutic Drug Monitoring Market: impact analysis
3. North America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
4. North America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
5. North America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
6. North America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
7. U.S. Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
8. U.S. Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
9. U.S. Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
10. U.S. Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
11. Canada Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
12. Canada Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
13. Canada Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
14. Canada Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
15. Europe Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
16. Europe Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
17. Europe Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
18. Europe Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
19. Germany Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
20. Germany Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
21. Germany Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
22. Germany Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
23. France Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
24. France Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
25. France Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
26. France Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
27. U.K. Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
28. U.K. Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
29. U.K. Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
30. U.K. Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
31. Italy Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
32. Italy Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
33. Italy Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
34. Italy Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
35. Spain Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
36. Spain Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
37. Spain Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
38. Spain Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
39. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
40. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
41. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
42. Rest of Europe Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
43. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
44. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
45. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
46. Asia Pacific Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
47. China Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
48. China Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
49. China Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
50. China Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
51. Japan Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
52. Japan Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
53. Japan Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
54. Japan Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
55. India Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
56. India Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
57. India Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
58. India Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
59. South Korea Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
60. South Korea Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
61. South Korea Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
62. South Korea Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
63. South-East Asia Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
64. South-East Asia Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
65. South-East Asia Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
66. South-East Asia Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
67. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
68. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
69. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
70. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
71. Latin America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
72. Latin America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
73. Latin America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
74. Latin America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
75. Brazil Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
76. Brazil Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
77. Brazil Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
78. Brazil Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
79. Mexico Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
80. Mexico Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
81. Mexico Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
82. Mexico Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
83. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
84. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
85. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
86. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
87. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
88. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
89. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
90. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
91. GCC Countries Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
92. GCC Countries Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
93. GCC Countries Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
94. GCC Countries Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
95. South Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
96. South Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
97. South Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
98. South Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
99. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
100. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
101. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
102. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )

Methodology

FrequentlyAsked Questions

Which key factors will influence Therapeutic Drug Monitoring market growth over 2022-2028?

The therapeutic drug monitoring market is predicted to develop due to factors such as an increase in demand for better healthcare in the urban population, an increase in the number of organ transplant surgeries, and the use of therapeutic drug monitoring in traditional anticancer therapy.

What will be the value of the Therapeutic Drug Monitoring market during 2022-2028?

According to the Market Research report, the global Therapeutic Drug Monitoring market was worth about 1692.90 (USD billion) in 2021 and is predicted to grow to around 2854.83 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 9.10 percent.

Which region will contribute notably towards the Therapeutic Drug Monitoring market value?

North America leads the global Therapeutic Drug Monitoring because of the region's technologically advanced healthcare infrastructure. Due to increased investments in the region, Asia-Pacific (APAC) is predicted to develop significantly during the forecast period of 2022 to 2029.

Which are the major players leveraging the Therapeutic Drug Monitoring market growth?

Some of the main competitors dominating the global Therapeutic Drug Monitoring market include - Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany), ApDia Group (Belgium), UTAK (US), Randox Laboratories Ltd. (Ireland), ARK Diagnostics, Inc. (US). BioTeZ Berlin-Buch GmbH (Germany), Eagle Biosciences, Inc. (US), Jasem Laboratory Systems and Solutions (Turkey), Aalto Scientific, Ltd. (US), Immundiagnostik AG (Germany), Sekisui Medical Co. Ltd. (Japan), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (UK), Chromsystems Instruments & Chemicals GmbH (Germany), and BÜHLMANN Laboratories (Switzerland).

Choose License Type

Single User License $4199.00 Multi User License $5199.00 Enterprise Access License $7199.00

Request Free Brochure

Ask for Customization

Free Analysis

Inquiry For Buying

List of Contents

Market Size Overview COVID-19 Impact:Growth Drivers Restraints Opportunities Segmentation Report Scope Recent Developments Regional Landscape Competitive Landscape Global market is segmented as follows:

RelatedNews

HappyClients

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We have secured system to process your transaction.

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed

Therapeutic Drug Monitoring Market Size, Share Report, Analysis, Trends, Growth 2030

Table Of Content

Table Of Figures

Table Of Tables

Methodology

Which key factors will influence Therapeutic Drug Monitoring market growth over 2022-2028?

What will be the value of the Therapeutic Drug Monitoring market during 2022-2028?

Which region will contribute notably towards the Therapeutic Drug Monitoring market value?

Which are the major players leveraging the Therapeutic Drug Monitoring market growth?

Choose License Type

List of Contents

How to Order

Disclaimer

FAQs

Return Policy

Sitemap

About Us

Terms and Conditions

Contact Us

Privacy Policy

ZMR in News

Career